Ozempic (injection) and Rybelsus (tablet) are FDA-approved to treat type 2 diabetes, and Wegovy is approved for weight loss
The best non-diabetic body-composition anchor favors tirzepatide, about 75:25 fat-to-lean loss in its DXA data versus about 62:38 in semaglutides. This is cross-trial evidence, not a head-to-head maintenance-dose DXA result
Ozempic, Mounjaro y Wegovy son frmacos antagonistas del receptor GLP-1
And when applied to the scalp, these regenerative properties translate directly to hair follicle health
Being aware of how each med is administered, what the dosage is, and what advantages and side effects to expect, will ensure you have the information you need for a discussion with your healthcare provider about which GLP-1 medication might be the best choice for your medical profile and personal health goals
In this article, we discuss white stretch marks and their causes